Researcher Profile

Ryoo, In Ja image
Ryoo, In Ja(류인자) 150

Chemical Biology Research Center (화학생물연구센터)

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 150 (Search time: 0.005 seconds).

No. Year Title Type
150 2022

2022Article

Near-infrared fluorescence probe for specific detection of acetylcholinesterase and imaging in live cells and zebrafishACS Applied Bio Materials, vol. 5, no. 5, pp. 2232-2239M M Fortibui; Mina Jang; S Lee; In Ja RyooJong Seog AhnSung-Kyun Ko; J Kim
Article
149 2022

2022Research Project

혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 장재혁 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
148 2022

2022Research Project

과기정통부 미생물 중앙은행 육성 = Advancement of Central Microbial Resource Center of the Ministry of Science and ICT연구책임자 : 김성건 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
147 2021

2021Patent

아실하이드라존 유도체를 포함하는 항염증 조성물JP2020-541492 (2020.08.29) / 6997331 (2021.12.20)안종석이희구김보연장재혁성낙균고성균; 안미자; 차현주황준성류인자, et al.
Patent
146 2021

2021Patent

신규한 인돌 유도체 및 이를 포함하는 항암 조성물CN201780024510.4 (2018.10.18) / ZL 2017800245104 (2021.12.10)안종석김보연장재혁성낙균; 라오; 이경호차현주황준성류인자고성균
Patent
145 2021

2021Patent

콜히친을 포함하는 알레르기성 피부 질환 또는 피부 소양증 치료용 조성물KR10-2020-0022083 (2020.02.24) / 10-2336218 (2021.12.09)안종석이희구김보연성낙균; 우민식; 차현주황준성류인자이경호
Patent
144 2021

2021Patent

신규한 인돌 유도체 및 이를 포함하는 항암 조성물2017221673 (2018.08.15) / 2017221673 (2021.09.30)안종석김보연장재혁성낙균; 라오; 이경호차현주황준성류인자고성균
Patent
143 2021

2021Patent

신규한 인돌 유도체 및 이를 포함하는 항암 조성물JP2018-543649 (2018.08.17) / 6917634 (2021.07.26)안종석김보연장재혁성낙균; 라오; 이경호차현주황준성류인자고성균
Patent
142 2021

2021Article

Dutomycin induces autophagy and apoptosis by targeting the serine protease inhibitor SERPINB6ACS Chemical Biology, vol. 16, no. 2, pp. 360-370Mina Jang; S Hara; Gun-Hee Kim; Seung Min Kim; Sangkeun Son; Mincheol Kwon; In Ja Ryoo; H Seo; M J Kim; N D Kim, et al.
Article
141 2021

2021Research Project

혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 차현주 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
140 2021

2021Research Project

과기정통부 미생물 중앙은행 육성 = Advancement of Central Microbial Resource Center of the Ministry of Science and ICT연구책임자 : 김성건 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
139 2020

2020Patent

항균 활성을 갖는 신규한 고리형 리포펩타이드계 화합물 및 이의 용도KR10-2018-0154155 (2018.12.04) / 10-2158205 (2020.09.15)안종석장재혁고성균; 손상근; 홍영수류인자
Patent
138 2020

2020Patent

신규 카테누리스포로라이드 유도체 및 이를 포함하는 말라리아 예방 및 치료용 약학 조성물KR10-2018-0144508 (2018.11.21) / 10-2152894 (2020.09.01)안종석장재혁; 손상근; 고성균홍영수류인자; 장민아
Patent
137 2020

2020Article

Kushenol E inhibits autophagy and impairs lysosomal positioning via VCP/p97 inhibitionBiochemical Pharmacology, vol. 175, pp. 113861-113861Mincheol Kwon; Mina Jang; Gun-Hee Kim; Taehoon Oh; In Ja RyooHyung Won RyuSei-Ryang OhBo Yeon KimJae-Hyuk JangSung-Kyun Ko, et al.
Article
136 2020

2020Article

Inhibition of osteoclasts differentiation by CDC2-induced NFATc1 phosphorylationBone, vol. 131, pp. 115153-115153Hye-Min Kim; L He; Sangku Lee; Chanmi park; Dong Hyun Kim; Ho Jin Han; Junyeol Han; Joonsung HwangHyunjoo ChaKyung Ho Lee, et al.
Article
135 2020

2020Article

CPPF, a novel microtubule targeting anticancer agent, inhibits the growth of a wide variety of cancersInternational Journal of Molecular Sciences, vol. 21, no. 13, pp. 4800-4800Ho Jin Han; Chanmi Park; Joonsung Hwang; N R Thimmegowda; Sun Ok Kim; Junyeol Han; Minsik Woo; B Shwetha; In Ja RyooKyung Ho Lee, et al.
Article
134 2020

2020Research Project

에피프로테옴 기반 발암 및 암전이 치료 신규 원천기술 개발연구책임자 : 김보연 / 사업기간 : 2020.07.01 ~ 2021.06.30
Research Project
133 2020

2020Research Project

혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 차현주 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
132 2019

2019Patent

신규한 매크로라이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 말라리아의 예방 또는 치료용 약학적 조성물KR10-2017-0128509 (2017.10.02) / 10-1987853 (2019.06.04)안종석김보연홍영수장재혁; 손상근; 고성균이경호류인자성낙균
Patent
131 2019

2019Article

Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancerBMB Reports, vol. 52, no. 5, pp. 342-347Dong Hyun Kim; Hye-Min Kim; P T T Huong; Ho Jin Han; Joonsung HwangHyunjoo ChaKyung Ho LeeIn Ja Ryoo; K E Kim; Y H Huh, et al.
Article
1 2 3 4 5 6 7 8